143 related articles for article (PubMed ID: 38783475)
1. Selective serotonin reuptake inhibitors use and dental implant failure: A call for awareness and caution.
Amjad A; Rehman H
J Pak Med Assoc; 2024 May; 74(5):1037. PubMed ID: 38783475
[No Abstract] [Full Text] [Related]
2. Prognostic Implication of Selective Serotonin Reuptake Inhibitors in Osseointegration of Dental Implants: A 5-year Retrospective Study.
Deepa ; Mujawar K; Dhillon K; Jadhav P; Das I; Singla YK
J Contemp Dent Pract; 2018 Jul; 19(7):842-846. PubMed ID: 30066689
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitors and dental implant failure-A significant concern in elders?
Gupta B; Acharya A; Pelekos G; Gopalakrishnan D; Kolokythas A
Gerodontology; 2017 Dec; 34(4):505-507. PubMed ID: 28744899
[TBL] [Abstract][Full Text] [Related]
4. Is mandibular osteomyelitis a sequela of SSRI-induced dental implant failure? A systematic review & case report.
Tarfa RA; Melder K; Mady LJ; Eibling D
Am J Otolaryngol; 2022; 43(1):103236. PubMed ID: 34583289
[TBL] [Abstract][Full Text] [Related]
5. Is the intake of selective serotonin reuptake inhibitors associated with an increased risk of dental implant failure?
Chrcanovic BR; Kisch J; Albrektsson T; Wennerberg A
Int J Oral Maxillofac Surg; 2017 Jun; 46(6):782-788. PubMed ID: 28222946
[TBL] [Abstract][Full Text] [Related]
6. Selective serotonin reuptake inhibitors and the risk of osseointegrated implant failure: a cohort study.
Wu X; Al-Abedalla K; Rastikerdar E; Abi Nader S; Daniel NG; Nicolau B; Tamimi F
J Dent Res; 2014 Nov; 93(11):1054-61. PubMed ID: 25186831
[TBL] [Abstract][Full Text] [Related]
7. Antidepressants may be linked to implant failure risk, researchers report.
Snider J
J Am Dent Assoc; 2014 Oct; 145(10):1016. PubMed ID: 25396238
[No Abstract] [Full Text] [Related]
8. Group 1 ITI Consensus Report: The influence of implant length and design and medications on clinical and patient-reported outcomes.
Jung RE; Al-Nawas B; Araujo M; Avila-Ortiz G; Barter S; Brodala N; Chappuis V; Chen B; De Souza A; Almeida RF; Fickl S; Finelle G; Ganeles J; Gholami H; Hammerle C; Jensen S; Jokstad A; Katsuyama H; Kleinheinz J; Kunavisarut C; Mardas N; Monje A; Papaspyridakos P; Payer M; Schiegnitz E; Smeets R; Stefanini M; Ten Bruggenkate C; Vazouras K; Weber HP; Weingart D; Windisch P
Clin Oral Implants Res; 2018 Oct; 29 Suppl 16():69-77. PubMed ID: 30328189
[TBL] [Abstract][Full Text] [Related]
9. Effects of different antidepressant classes on dental implant failure: A retrospective clinical study.
Hakam AE; Vila G; Duarte PM; Mbadu MP; Ai Angary DS; Shuwaikan H; Aukhil I; Neiva R; da Silva HDP; Chang J
J Periodontol; 2021 Feb; 92(2):196-204. PubMed ID: 32725908
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin reuptake inhibitors as a risk factor for dental implant failure: a retrospective clinical study.
Rodríguez-Pena K; Salgado-Peralvo ÁO; Kewalramani N; Suárez-Quintanilla JA; Suárez-Quintanilla JM
Br J Oral Maxillofac Surg; 2022 Dec; 60(10):1347-1352. PubMed ID: 36411146
[TBL] [Abstract][Full Text] [Related]
11. Systemic Intake of Proton Pump Inhibitors and Selective Serotonin Reuptake Inhibitors May Be Associated With Implant Failure.
Cheng LL
J Evid Based Dent Pract; 2020 Sep; 20(3):101466. PubMed ID: 32921386
[TBL] [Abstract][Full Text] [Related]
12. Does the Intake of Selective Serotonin Reuptake Inhibitors Negatively Affect Dental Implant Osseointegration? A Retrospective Study.
Altay MA; Sindel A; Özalp Ö; Yildirimyan N; Kader D; Bilge U; Baur DA
J Oral Implantol; 2018 Aug; 44(4):260-265. PubMed ID: 29517407
[TBL] [Abstract][Full Text] [Related]
13. Selective Serotonin Reuptake Inhibitors and Dental Implant Failure: A Systematic Review and Meta-Analysis.
Shariff JA; Gurpegui Abud D; Bhave MB; Tarnow DP
J Oral Implantol; 2023 Aug; 49(4):436-443. PubMed ID: 37527173
[TBL] [Abstract][Full Text] [Related]
14. Association of selective serotonin reuptake inhibitor use with marginal bone level changes around osseointegrated dental implants: A retrospective study.
Kotsailidi EA; Gagnon C; Johnson L; Basir AB; Tsigarida A
J Periodontol; 2023 Aug; 94(8):1008-1017. PubMed ID: 36738270
[TBL] [Abstract][Full Text] [Related]
15. Drug-associated bone resorption with potential dental and implant implications.
Romanos GE; Vaglica M; Sculean A
Periodontol 2000; 2022 Oct; 90(1):236-246. PubMed ID: 35916776
[TBL] [Abstract][Full Text] [Related]
16. Medication-related dental implant failure: Systematic review and meta-analysis.
Chappuis V; Avila-Ortiz G; Araújo MG; Monje A
Clin Oral Implants Res; 2018 Oct; 29 Suppl 16():55-68. PubMed ID: 30328197
[TBL] [Abstract][Full Text] [Related]
17. Relationship between Selective Serotonin Reuptake Inhibitors and Risk of Dental Implant Failure.
Carr AB; Gonzalez RLV; Jia L; Lohse CM
J Prosthodont; 2019 Mar; 28(3):252-257. PubMed ID: 30637850
[TBL] [Abstract][Full Text] [Related]
18. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.
Anderson IM; Tomenson BM
BMJ; 1995 Jun; 310(6992):1433-8. PubMed ID: 7613276
[TBL] [Abstract][Full Text] [Related]
19. Extrapyramidal symptoms with selective serotonin reuptake inhibitors.
Arya DK
Br J Psychiatry; 1994 Dec; 165(6):728-33. PubMed ID: 7881774
[TBL] [Abstract][Full Text] [Related]
20. Findings from selective serotonin reuptake inhibitor-exposed neonates should be interpreted with caution.
Norton JD; Worley LL; Lowery CL
Pediatrics; 2004 Dec; 114(6):1739-40; author reply 1740-1. PubMed ID: 15574649
[No Abstract] [Full Text] [Related]
[Next] [New Search]
